Origins of HIV and the AIDS Pandemic
Open accessThe DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Abstract
Acquired immunodeficiency syndrome (AIDS) of humans is caused by two lentiviruses, human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2). Here, we describe the origins and evolution of these viruses, and the circumstances that led to the AIDS pandemic. Both HIVs are the result of multiple cross-species transmissions of simian immunodeficiency viruses (SIVs) naturally infecting African primates. Most of these transfers resulted in viruses that spread in humans to only a limited extent. However, one transmission event, involving SIVcpz from chimpanzees in southeastern Cameroon, gave rise to HIV-1 group M-the principal cause of the AIDS pandemic. We discuss how host restriction factors have shaped the emergence of new SIV zoonoses by imposing adaptive hurdles to cross-species transmission and/or secondary spread. We also show that AIDS has likely afflicted chimpanzees long before the emergence of HIV. Tracing the genetic changes that occurred as SIVs crossed from monkeys to apes and from apes to humans provides a new framework to examine the requirements of successful host switches and to gauge future zoonotic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“HIV-2 differs from HIV-1 in that it contains Vpx, an accessory protein that shares a common genetic ancestor with Vpr55 but is lacking from all HIV-1 genomes.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [55]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple, Fast, and Accurate Algorithm to Estimate Large Phylogenies by Maximum Likelihood
Guindon, S., & Gascuel, O. (2003) · Systematic Biology · doi:10.1080/10635150390235520 · Cited by 16,806 · cited 1×
“The phylogenetic tree was estimated using maximum likelihood methods (Guindon and Gascuel 2003).”
MethodBarré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038 · cited 1×
“A retrovirus, now termed human immunodeficiency virus type 1 (HIV-1), was subsequently identified as the causative agent of what has since become one of the most devastating infectious diseases to have emerged in recent history (Barre-Sinoussi et al. 1983; Gallo et al. 1984; Popovic et al. 1984).”
BackgroundRapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267 · cited 2×
“time is short (Ho et al. 1995; Wei et al. 1995).”
BackgroundGallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641 · cited 1×
“A retrovirus, now termed human immunodeficiency virus type 1 (HIV-1), was subsequently identified as the causative agent of what has since become one of the most devastating infectious diseases to have emerged in recent history (Barre-Sinoussi et al. 1983; Gallo et al. 1984; Popovic et al. 1984).”
BackgroundPopovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200935 · Cited by 3,535
The Chimpanzees of Gombe: Patterns of Behavior
Goodall, J. R. (1986) · DigitalGeorgetown (Georgetown University Library) · Cited by 3,384
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260 · cited 2×
“time is short (Ho et al. 1995; Wei et al. 1995).”
BackgroundSelf-citationIsolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902 · cited 4×
“2004); and (3) tetherin (also termed BST-2 and CD317) which inhibits the budding and release of virions from infected cells (Neil et al. 2008).”
BackgroundInfluentialThe cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816 · cited 1×
“…which interferes with reverse transcription (Sheehy et al. 2002); (2) TRIM5a (tripartite motif 5a protein), which interferes with viral uncoating (Stremlau et al. 2004); and (3) tetherin (also termed BST-2 and CD317) which inhibits the budding and release of virions from infected cells (Neil et…”
Background
Research works printed but not linked: 2
- Groves C. 2001. Primate taxonomy. Smithsonian Institution Press, Washington, DC.
- Li Y, Ndjango J-B, Learn G, Robertson J, Takehisa J, Bibollet-Ruche F, Sharp P, Worobey M, Shaw G, Hahn B. 2010. Molecular epidemiology of simian immunodefi- ciency virus in eastern chimpanzees and gorillas. In 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA.
Cited by
Items 401–500 of 1,000
Queirós, N., & Torres, T. R. (2018) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2018.02.020 · Cited by 21
Loss of CXCR6 coreceptor usage characterizes pathogenic lentiviruses
Wetzel, K. S., Yi, Y., Yadav, A., Bauer, A. M., Bello, E. A., Romero, D. C., Bibollet‐Ruche, F., Hahn, B. H., Paiardini, M., Silvestri, G., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007003 · Cited by 17
“Cells were then infected with four SIVcpz strains reflecting diverse host and molecular lineages [56]: SIVcpzPts BF1167, isolated from P.”
MethodSelf-citationHeusinger, E., Deppe, K., Sette, P., Krapp, C., Kmieć, D., Kluge, S. F., Marx, P. A., Apetrei, C., Kirchhoff, F., & Sauter, D. (2018) · Journal of Virology · doi:10.1128/jvi.00276-18 · Cited by 17
Racial Discrimination, Protective Processes, and Sexual Risk Behaviors Among Black Young Males
Hicks, M. R., & Kogan, S. M. (2019) · Archives of Sexual Behavior · doi:10.1007/s10508-018-1341-1 · Cited by 18
Ntumvi, N. F., Ndze, V. N., Gillis, A. N., Diffo, J. L. D., Tamoufé, U., Takuo, J. M., Mouiche, M. M. M., Nwobegahay, J. M., LeBreton, M., Rimoin, A. W., et al. (2022) · Virus Evolution · doi:10.1093/ve/veab110 · Cited by 18
“The best example for this may be HIV, which originated from multiple non-human primate (NHP) spillover events in Africa during the early 20th century, and it also applies to measles virus, influenza A viruses, and others (Weiss et al. 2003; Sharp and Hahn 2011).”
BackgroundHepatitis B Virus Genotype G: The Odd Cousin of the Family
Araujo, N. M., & Osiowy, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.872766 · Cited by 17
The potential role of exosomal miRNAs and membrane proteins in acute HIV-infected people
Li, X., Wang, W., Chen, J., Xie, B., Luo, S., Chen, D., Cai, C. Y. L., Li, C., & Li, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.939504 · Cited by 17
“The most common transmission routes include anal or vaginal sex, sharing needles, syringes, or other drug-injection equipment, and mother-to-child transmission (2, 3).”
BackgroundMahan, M. J., Kubicek-Sutherland, J. Z., & Heithoff, D. M. (2013) · Virulence · doi:10.4161/viru.23380 · Cited by 22
Woodford, L., & Evans, D. J. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa070 · Cited by 18
Banchenko, S., Krupp, F., Gotthold, C., Bürger, J., Graziadei, A., O’Reilly, F. J., Sinn, L., Ruda, O., Rappsilber, J., Spahn, C. M. T., et al. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009775 · Cited by 18
Dunuweera, A. N., Dunuweera, S. P., & Kapilan, R. (2024) · Biochemistry Research International · doi:10.1155/2024/8273237 · Cited by 22
“For monitoring the transmission of HIV between heterosexual males and females, luciferase-inserted SIV (simian immunodefciency virus), exhibiting similar behavior to HIV, has been employed [155].”
MethodZhang, Z., Gu, Q., Vasudevan, A. A. J., Jeyaraj, M., Schmidt, S., Zielonka, J., Perković, M., Heckel, J., Cichutek, K., Häussinger, D., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01497-16 · Cited by 16
“obtained from sooty mangabey monkeys (smm) (1).”
Virus and microbiota relationships in humans and other mammals: An evolutionary view
Lima, M. T., Andrade, A. C. D. S. P., Oliveira, G. P., Nicoli, J. R., Martins, F. S., Kroon, E. G., & Abrahão, J. S. (2019) · Human Microbiome Journal · doi:10.1016/j.humic.2018.11.001 · Cited by 19
Sebastião, C. S., Neto, Z., de Jesus, C. S., Mirandela, M., Jandondo, D., Couto-Fernandez, J. C., Tanuri, A., Morais, J. F. M., & Brito, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225251 · Cited by 16
“HIV-1 is responsible for the vast majority of HIV infections [4].”
BackgroundQiu, Y., Wang, Q., Li, J., Liao, C.-H., Zhou, Z., & Ge, X. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13792 · Cited by 17
Wang, X., Zhang, Y., Liu, Y., Li, H., Jia, L., Han, J., Li, T., Wang, X., Li, J., Wen, H., et al. (2021) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0190 · Cited by 16
“First, since the sequence data in the database we selected include only the pol region (2,253–3,252), we could only define potential CRFs rather than CRFs, which may also underestimate the diversity and frequency of HIV-1 recombination in China.”
Farhadian, M., Mohammadi, Y., Mirzaei, M., & Khorram, N. S. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05523-w · Cited by 16
COVID-19 Pandemic: Public Health Risk Assessment and Risk Mitigation Strategies
Kim, D.-Y., Shinde, S. K., Lone, S., Palem, R. R., & Ghodake, G. S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121243 · Cited by 19
Carvajal, M., Sáenz, C., Fuentes, N., Guevara, R., Muñoz, E. B., Prado-Vivar, B., Díaz, E. A., Alfonso-Cortes, F., Coloma, J., Grunauer, M., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.02741-23 · Cited by 16
Development of HIV-1 integrase inhibitors: recent molecular modeling perspectives
Su, M., Tan, J., & Lin, C. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.012 · Cited by 16
Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV‐1 infection
Deng, Q., Chen, Z., Shi, L., & Lin, H. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.1998 · Cited by 18
“HIV infection includes three main stages: acute infection, clinical latency, and AIDS.11,12 Up to now, although the combination ART has successfully decreased the morbidity and mortality in HIV‐infected persons, one of the major limitations of ARTs is that it cannot eradicate the latent HIV‐1 reservoir.”
BackgroundInfluentialWiginton, J. M., King, E. J., & Fuller, A. O. (2018) · Global Public Health · doi:10.1080/17441692.2018.1524921 · Cited by 16
“Several intervention participants recalled the impact of learning about the origin of HIV through zoonotic transfer from primates (Sharp & Hahn, 2011) and about why the virus can only survive in, and thus is only transmitted by, a few bodily fluids.”
BackgroundIn Vivo Imaging-Driven Approaches to Study Virus Dissemination and Pathogenesis
Uchil, P. D., Haugh, K. A., Pi, R., & Mothes, W. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041429 · Cited by 16
“Most devastating viral diseases originate from such cross-species transmissions—for example, influenza (birds to humans or via pigs as intermediates) (4), human immunodeficiency virus-1 (HIV-1) (chimpanzees to humans) (5), severe acute respiratory syndrome (civet cats to humans) (6), rabies (animals to humans) (7), an…”
BackgroundSaleemi, M. A., Ahmad, B., Benchoula, K., Vohra, M. S., Mea, H. J., Chong, P. P., Palanisamy, N. K., & Wong, E. H. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104583 · Cited by 16
“Notably, the virus mutated into HIV from its origins and gradually spread from Africa to other parts of the world (Sharp and Hahn, 2011; Ayouba et al., 2013; Sousa et al., 2017).”
Novel MHC class I full-length allele and haplotype characterization in sooty mangabeys
Heimbruch, K. E., Karl, J. A., Wiseman, R. W., Dudley, D. M., Johnson, Z., Kaur, A., & O’Connor, D. H. (2015) · Immunogenetics · doi:10.1007/s00251-015-0847-0 · Cited by 16
Guatelli, J., Siliciano, R. F., Kuritzkes, D. R., & Richman, D. D. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch34 · Cited by 16
Can Science Help Resolve the Controversy on the Origins of the SARS-CoV-2 Pandemic?
Casadevall, A., Weiss, S. R., & Imperiale, M. J. (2021) · mBio · doi:10.1128/mbio.01948-21 · Cited by 16
The HIV/AIDS epidemic in Grenada
Chaudhry, M. R., Husain, F., Armstrong, E. G., & Ferguson, J. A. (2018) · Medicine · doi:10.1097/md.0000000000010869 · Cited by 15
“HIV/AIDS is caused by viral strains HIV-1 and HIV-2, the latter having almost negligible implications in the transmission and prevalence of the disease in the human population.([1]) Viral strain, HIV-1, is highlighted for its high pathogenicity and prevalence associated with human infections.”
BackgroundBarin, F. (2022) · La Presse Médicale · doi:10.1016/j.lpm.2022.104128 · Cited by 20
Absence of Staphylococcus aureus in Wild Populations of Fish Supports a Spillover Hypothesis
Matuszewska, M., Dabrowska, A., Murray, G. G. R., Kett, S., Vick, A. J. A., Banister, S. C., Muñoz, L. P., Cunningham, P., Welch, J. J., Holmes, M. A., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04858-22 · Cited by 16
Bozzo, C. P., Laliberté, A., Luna, A. D., Pastorio, C., Regensburger, K., Krebs, S., Graf, A., Blum, H., Volčič, M., Sparrer, K. M. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48228-x · Cited by 18
“While more analysis of the hits could always be added (some might want this for Nature Comm), I think the paper has achieved enough for presentation.”
Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1
Luo, D., Luo, R., Wang, W., Deng, R., Wang, S., Ma, X., Pu, C., Liu, Y., Zhang, H., Yu, S., et al. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129880 · Cited by 17
Paediatric HIV-1 infection: updated strategies of prevention mother-to-child transmission
Lumaca, A., Galli, L., de Martino, M., & Chiappini, E. (2018) · Journal of Chemotherapy · doi:10.1080/1120009x.2018.1451030 · Cited by 15
Bowder, D., Hollingsead, H., Durst, K., Hu, D., Wei, W., Wiggins, J., Medjahed, H., Finzi, A., Sodroski, J., & Xiang, S.-H. (2018) · Virology · doi:10.1016/j.virol.2018.06.005 · Cited by 16
“T is specific for HIV-1 subtype B strains or also applies to other HIV-1 subtypes or evolutionarily related primate lentiviruses (Hirsch et al., 1995; Sharp and Hahn, 2011).”
BackgroundBanin, A. N., Tuen, M., Bimela, J. S., Tongo, M., Zappile, P., Khodadadi‐Jamayran, A., Nanfack, A. J., Okonko, I. O., Meli, J., Wang, X., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25362 · Cited by 15
“Cross-species transmission events from chimpanzees and other monkeys to hunters and butchers are supposed to be initiators of the HIV epidemic in humans [2-5].”
BackgroundMakgoo, L., Mosebi, S., & Mbita, Z. (2022) · Non-coding RNA Research · doi:10.1016/j.ncrna.2022.07.003 · Cited by 16
“categorised into four groups; namely, O (Outlier), M (Major), N (non-M, non-O), and lastly, P group, which was the last group to be discovered [16].”
BackgroundGrowing shreds of evidence for monkeypox to be a sexually transmitted infection
Amer, F. A., Hammad, N., Wegdan, A. A., ELBadawy, N. E., Pagliano, P., & Rodriguez-Morales, A. J. (2022) · Infezioni in Medicina · doi:10.53854/liim-3003-1 · Cited by 15
Tunç, H., Doğan, B., Darendeli-Kiraz, B. N., Sarı, M., Durdağı, S., & Kotil, S. (2023) · PeerJ · doi:10.7717/peerj.14987 · Cited by 15
Small but Highly Versatile: The Viral Accessory Protein Vpu
Volčič, M., Wiesmüller, L., & Kirchhoff, F. (2023) · Annual Review of Virology · doi:10.1146/annurev-virology-111821-100816 · Cited by 15
Wieczorek, L., Sanders‐Buell, E., Zemil, M., Lewitus, É., Kavusak, E., Heller, J., Molnar, S., Rao, M., Smith, G., Bose, M., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011780 · Cited by 17
Enhanced Heterosexual Transmission Hypothesis for the Origin of Pandemic HIV-1
de Sousa, J. D., Álvarez, C., Vandamme, A., & Müller, V. (2012) · Viruses · doi:10.3390/v4101950 · Cited by 19
Yu, H., Li, C., Wang, X., Duan, J., Yang, N., Xie, L., Yu, Y., Li, S., Bi, C., Yang, B., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00372 · Cited by 15
A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes
Rustanti, L., Jin, H., Lor, M., Lin, M., Rawle, D. J., & Harrich, D. (2017) · Virology Journal · doi:10.1186/s12985-017-0705-9 · Cited by 15
“Subtype C is predominant in sub Saharan Africa, India and South America [21], while subtype D and recombinant A/D are increasing in sub-Saharan Africa [22, 23].”
BackgroundEvans, T., Olson, S. H., Watson, J. E. M., Gruetzmacher, K., Pruvot, M., Jupiter, S. D., Wang, S., Clements, T., & Jung, K. (2020) · doi:10.19121/2020.report.37426 · Cited by 16
Reiss, E. I. M. M., van Haaren, M. M., van Schooten, J., Claireaux, M. A. F., Maisonnasse, P., Antanasijevic, A., Allen, J. D., Bontjer, I., Torres, J. L., Lee, W.-H., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00576-9 · Cited by 14
Mishra, S. K., Guendouzi, A., Kumar, N., Sharma, G., Alqahtani, T., Zaki, M. E. A., Mashud, M. A. A., Tiruneh, Y. K., & Georrge, J. J. (2025) · Virology Journal · doi:10.1186/s12985-025-02764-0 · Cited by 17
“Human Immunodeficiency Virus (HIV) is one the leading endemics, and due to its complex mechanism, it is the most challenging virus for the world to design therapeutics against, as it leads to severe complications in the infected person and can lead to death [1,2].”
Tambo, E., Yah, C. S., Ugwu, C. E., Olalubi, O. A., Wurie, I., Jonhson, J. K., & Ngogang, J. Y. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6875 · Cited by 14
Dube, B. R., Marshall, T. P., & Ryan, R. P. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0333-2 · Cited by 14
“Background Human immunodeficiency virus (HIV) is a viral infection that weakens the immune system and is a subsequent causative agent of acquired immunodeficiency syndrome (AIDS) [1].”
BackgroundIntroduction to Temporal Network Epidemiology
Masuda, N., & Holme, P. (2017) · Theoretical biology · doi:10.1007/978-981-10-5287-3_1 · Cited by 28
SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack
Evans, N. J., Martinez, E., Petrosillo, N., Nichols, J., Islam, E. A., Pruitt, K., & Almodóvar, S. (2021) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s300055 · Cited by 15
An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins
Bosso, M., Stürzel, C. M., Kmieć, D., Badarinarayan, S. S., Braun, E., Ito, J., Sato, K., Hahn, B. H., Sparrer, K. M. J., Sauter, D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109735 · Cited by 14
“Human immunodeficiency virus type 1 (HIV-1) is the consequence of at least four independent zoonotic transmissions of simian immunodeficiency viruses (SIVs) infecting great apes giving rise to groups M, N, O, and P (Sauter and Kirchhoff, 2019; Sharp and Hahn, 2011).”
Self-citationGenetic diversity and drug resistance mutations of HIV-1 in Leningrad Region
Shchemelev, A. N., Семенов, А. В., Ostankova, Y. V., Zueva, E. B., Valutite, D. E., Semenova, D. A., Davydenko, V. S., & Тотолян, А. А. (2022) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-216 · Cited by 14
Nasrallah, G. K., Albuainain, R., Younes, N., Dargham, S. R., Al‐Sadeq, D. W., Elhassan, M., Shaar, I. A., Yassine, H. M., Abu-Raddad, L. J., Emara, M. M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0278079 · Cited by 15
Cellular Targets of HIV-1 Protease: Just the Tip of the Iceberg?
Centazzo, M., Manganaro, L., & Alvisi, G. (2023) · Viruses · doi:10.3390/v15030712 · Cited by 14
“Since its adaptation to humans at the beginning of the 20th century [1], more than 84 million people have been infected, resulting in one of the largest epidemics in human history [2].”
BackgroundWood, M. P., Cole, A. L., Eade, C. R., Chen, L., Chai, K. X., & Cole, A. M. (2014) · Immunology · doi:10.1111/imm.12278 · Cited by 14
McCarthy, K. R., & Johnson, W. E. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004017 · Cited by 15
“Since the discoveries of HIV-1 and HIV-2 in humans and SIVmac in captive macaques, over 40 primate lentiviruses have been identified, all in African primates [7].”
BackgroundInfluentialBego, M. G., Cong, L., Mack, K., Kirchhoff, F., & Cohen, É. A. (2016) · Journal of Virology · doi:10.1128/jvi.01131-16 · Cited by 14
“HIV-1 is divided into four distinct groups (groups M, N, O, and P), which represent independent cross-species transmissions of a simian immunodeficiency virus (SIV) to humans (13).”
BackgroundWhy Are Nigeria-Cameroon Chimpanzees (Pan troglodytes ellioti) Free of SIVcpz Infection?
Locatelli, S., Harrigan, R. J., Clee, P. R. S., Mitchell, M. W., McKean, K. A., Smith, T. B., & Gonder, M. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160788 · Cited by 18
“We know that SIVcpz was capable of crossing species boundaries on more than one occasion in southern Cameroon [9,51], and that SIVcpz can infect the P.”
BackgroundYamamoto, M., Koga, R., Fujino, H., Shimagaki, K., Ciftci, H. I., Kamo, M., Tateishi, H., Otsuka, M., & Fujita, M. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000701 · Cited by 15
Vasavi, C. S., Tamizhselvi, R., & Munusami, P. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.06.007 · Cited by 14
Bhalerao, A., & Cucullo, L. (2019) · Journal of Public Health · doi:10.1007/s10389-019-01062-8 · Cited by 14
The WetNet: What the Oral Polio Vaccine Hypothesis Exposes about Globalized Interspecies Fluid Bonds
Jain, S. L. (2020) · Medical Anthropology Quarterly · doi:10.1111/maq.12587 · Cited by 14
“…narrative elegantly combines—albeit speculatively—science and social history to account for the various HIV types and sub-types (Gilbert et al. 2007; Sharp and Hahn 2011; Worobey et al. 2003, 2016).1 In 1999, British journalist Edward Hooper described an alternative theory, also tastefully…”
BackgroundSpecific Guanosines in the HIV-2 Leader RNA are Essential for Efficient Viral Genome Packaging
Umunnakwe, C. N., Duchon, A., Nikolaitchik, O. A., Rahman, S. A., Liu, Y., Chen, J., Tai, S., Pathak, V. K., & Hu, W.-S. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.11.017 · Cited by 13
Alexiev, I., Campbell, E. M., Knyazev, S., Pan, Y., Grigorova, L., Dimitrova, R., Partsuneva, A., Gancheva, A., Kostadinova, A., Seguin‐Devaux, C., et al. (2021) · Viruses · doi:10.3390/v13010116 · Cited by 14
“Currently, HIV-1 is divided into four phylogenetically distinct groups: M (major), N (new), O (outlier), and P representing independent zoonotic events from simian immunodeficiency virus (SIV) in chimpanzees and gorillas to HIV in humans [4].”
BackgroundReid, M. J. C., Switzer, W. M., Schillaci, M. A., Ragonnet‐Cronin, M., Joanisse, I., Caminiti, K., Lowenberger, C. A., Galdikas, B. M. F., Sandstrom, P. A., & Brooks, J. (2016) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2016.05.036 · Cited by 15
Obura, H. O., Mlay, C. D., Moyo, L., Karumbo, B. M., Omar, K. M., Sinza, E., Rotich, G. J., Mudaki, W., Kamau, B. M., Awe, O. I., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.18.492401 · Cited by 14
Rashid, F., Zaongo, S. D., Iqbal, H., Harypursat, V., Song, F., & Chen, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1390650 · Cited by 14
“The Vpu gene is present in HIV-1, and is absent in HIV-2, rhesus macaque SIV (SIVmac), and sooty mangabey SIV (SIVsmm) (73 – 75).”
BackgroundShabbir, N. A., Kant, S. B., Rashid, K., Hafeez, U., Akbar, A. A., Batool, S. W., Pranto, A. H., Zaman, J., Tonmoy, H. S., Islam, M. R., et al. (2024) · Medicine · doi:10.1097/md.0000000000040339 · Cited by 13
Mugisha, N., Ghanem, L., Komi, O. A., Noureddine, R., Shariff, S., Wojtara, M. S., Nanehkeran, M. M., & Uwishema, O. (2025) · Health Science Reports · doi:10.1002/hsr2.70727 · Cited by 13
Short Communication: Reassessing the Origin of the HIV-1 CRF02_AG Lineages Circulating in Brazil
Delatorre, E. O., Velasco-de-Castro, C. A., Pilotto, J. H., Couto-Fernandez, J. C., Bello, G., & Morgado, M. G. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0183 · Cited by 13
“The human immunodeficiency virus type 1 (HIV-1) is classified into four groups (M, N, O, and P), each one representing independent zoonotic transmission events to humans.(1) The M group is responsible for the worldwide pandemic, having evolved and diversified into different clades,(2) characterized by an extensive gen…”
Selective use of primate CD4 receptors by HIV-1
Warren, C. J., Meyerson, N. R., Dirasantha, O., Feldman, E. R., Wilkerson, G. K., & Sawyer, S. L. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000304 · Cited by 14
“From this point forward, we focused on CD4 receptors from a subset of primate species, in particular the African primate species involved in the zoonotic transmissions of HIV-1 (chimpanzees and gorillas) and HIV-2 (sooty mangabeys) [17] , and the macaque species that serve as the current laboratory model for HIV-1 (ex…”
BackgroundPimentel, A. C., Beraldo, C. S., & Cogni, R. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0197 · Cited by 15
The impact of the COVID-19 pandemic on U.S. orthodontic practices in 2020
Motevasel, H., Helms, L. R., Eckert, G. J., Stewart, K. T., & Albright, D. A. (2021) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2020.11.040 · Cited by 18
Hlophe, L. D., Tamuzi, J. L., Shumba, C. S., & Nyasulu, P. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273435 · Cited by 13
Vaill, M., Kawanishi, K., Varki, N. M., Gagneux, P., & Varki, A. P. (2023) · Physiological Reviews · doi:10.1152/physrev.00040.2021 · Cited by 14
Insights into the oligomeric structure of the HIV-1 Vpu protein
Majeed, S., Adetuyi, O. A., Borbat, P. P., Islam, M. M., Ishola, O., Zhao, B., & Georgieva, E. R. (2023) · Journal of Structural Biology · doi:10.1016/j.jsb.2023.107943 · Cited by 13
Computer-aided drug design in seeking viral capsid modulators
Zhao, S., Zhang, X., da Silva‐Júnior, E. F., Zhan, P., & Liu, X. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103581 · Cited by 14
Solid-Phase Optical Sensing Techniques for Sensitive Virus Detection
Seymour, E. Ç., Kanık, F. E., Gür, S. D., Bakhshpour, M., Araz, A., Ünlü, N. L., & Ünlü, M. S. (2023) · Sensors · doi:10.3390/s23115018 · Cited by 14
“Human history has witnessed several outbreaks caused by viruses such as the plague [2], cholera [3], flu [4], and HIV [5].”
BackgroundNguyen, P. V., Wessels, J. M., Mueller, K., Vahedi, F., Anipindi, V. C., Verschoor, C. P., Chew, M. V., Deshière, A., Karniychuk, U. U., Mazzulli, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15630-z · Cited by 13
Monkey Models and HIV Vaccine Research
Chen, Z. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0484-2_5 · Cited by 13
Mullane, K., & Williams, M. J. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.01.004 · Cited by 14
Loss of Nef-mediated CD3 down-regulation in the HIV-1 lineage increases viral infectivity and spread
Mesner, D., Hotter, D., Kirchhoff, F., & Jolly, C. L. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921135117 · Cited by 13
Como será o amanhã? O mundo pós-pandemia
Guenther, M. (2020) · Revista Brasileira de Educação Ambiental (RevBEA) · doi:10.34024/revbea.2020.v15.10766 · Cited by 33
Siniavin, A. E., Grinkina, S. D., Osipov, A. V., Starkov, V. G., Tsetlin, V. I., & Utkin, Y. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031610 · Cited by 13
Simpson, J., Kozak, C. A., & Boso, G. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010458 · Cited by 13
Bergquist, R. N., Zheng, J., & Zhou, X. (2024) · Science in One Health · doi:10.1016/j.soh.2024.100070 · Cited by 13
“Examples from the last century cover a spectrum of such pathogens ranging from in fl uenza virus [13] to the human immunode fi ciency virus (HIV) [14] and the three coronaviruses, which caused the severe acute respiratory syndrome (SARS) [15], the Middle East respiratory syndrome (MERS) [16] and the…”
BackgroundPeptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases
Chandarana, C. V., Juwarwala, I., Shetty, S., & Bose, A. (2024) · Current Drug Research Reviews · doi:10.2174/0125899775295960240406073630 · Cited by 14
Gotora, P. T., Brown, K., Martin, D. R., van der Sluis, R., Cloete, R. E. A., & Williams, M. E. (2024) · Virology Journal · doi:10.1186/s12985-024-02419-6 · Cited by 12
“The Group M viruses are further subdivided into nine subtypes A-D, F-H, J and K [8].”
BackgroundEl SARS-CoV-2 y otros virus emergentes y su relación con la inocuidad en la cadena alimentaria
Silva-Jaimes, M. I. (2020) · Scientia Agropecuaria · doi:10.17268/sci.agropecu.2020.02.15 · Cited by 16
Effect of climate change on food production (animal products)
Wu, H., & Etienne, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822373-4.00019-7 · Cited by 13
The Gombe Ecosystem Health Project: 16 years of program evolution and lessons learned
Lonsdorf, E. V., Travis, D. A., Raphael, J., Kamenya, S. M., Lipende, I. F., Mwacha, D., Collins, D., Wilson, M. L., Mjungu, D. C., Murray, C. M., et al. (2021) · American Journal of Primatology · doi:10.1002/ajp.23300 · Cited by 13
Self-citationGeorge, C. R. R., Jeffery, H. E., & Lahra, M. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-84168-3_9 · Cited by 19
Using Environmental Sampling to Enable Zoonotic Pandemic Preparedness
Sanyal, A., Agarwal, S., Ramakrishnan, U., Garg, K. M., & Chattopadhyay, B. (2022) · Journal of the Indian Institute of Science · doi:10.1007/s41745-022-00322-z · Cited by 13
SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level
Demoliou-Mason, C. D., Papaneophytou, C. P., & Nicolaidou, V. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.73134 · Cited by 15
Reversions to consensus are positively selected in HIV-1 and bias substitution rate estimates
Druelle, V., & Neher, R. A. (2022) · Virus Evolution · doi:10.1093/ve/veac118 · Cited by 12
Palmal, S., Saha, S., & Tripathy, S. (2023) · Soft Computing · doi:10.1007/s00500-023-08431-2 · Cited by 12
Expanding therapeutic options: lenacapavir + bictegravir as a potential treatment for HIV
Doan, J., Brunzo-Hager, S., Satterly, B., & Cory, T. J. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2294918 · Cited by 12
Machado, L. F. A., Costa, I. B., Folha, M. N., da Luz, A. L. B., Vallinoto, A. C. R., Ishak, R., & Ishak, M. O. G. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2392-y · Cited by 12
“The M group may be further divided into subtypes, subsubtypes, circulating recombinant forms (CRF), and unique recombinant forms (URF) [1].”
BackgroundAndrade-Ochoa, S., García‐Machorro, J., Bello, M., Rodrı́guez-Valdez, L. M., Flores-Sandoval, C. A., & Correa‐Basurto, J. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1352538 · Cited by 12
“Antiretroviral therapy has dramatically reduced disease progression and death among patients with infection (Hemelaar, Gouws, Ghys, & Osmanov, 2011; Sharp & Hahn, 2011); however, AIDS remains a major public health problem.”
Background
Metadata
- Authors
- Sharp, P. M., & Hahn, B. H.
- Affiliations
- Centre for Immunity, Infection and Evolution (GB)
- University of Pennsylvania (US)
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-09-01
- Volume
- 1
- Issue
- 1
- Pages
- a006841-a006841
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC3234451
- OpenAlex
- W2159181197
- Cited by
- 1,496
- References
- 154
- Citations by year
- 2026: 63 · 2025: 88 · 2024: 112 · 2023: 167 · 2022: 122 · 2021: 166 · 2020: 139 · 2019: 125 · 2018: 91 · 2017: 79 · 2016: 104 · 2015: 72 · 2014: 71 · 2013: 58 · 2012: 31
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI058715, R01AI050529, P30AI027767)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Zoonotic diseases and public health
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV origin, HIV/AIDS epidemic, HIV-1 group M, HIV-2, simian immunodeficiency virus, SIVcpz, chimpanzees, interspecies transmission, zoonotic emergence, host restriction factors, host switching, zoonotic risk, African primates
- MeSH terms
- Acquired Immunodeficiency Syndrome, Animals, Pan troglodytes, Disease Vectors, Biological Evolution, Humans, Phylogeny, Global Health, Zoonoses, Simian Immunodeficiency Virus, HIV-1, HIV-2, Simian Acquired Immunodeficiency Syndrome, Ape Diseases, Host-Pathogen Interactions, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.